Association Between Anthropometric Indices and Vitamin D Levels: Results From the Yazd Health Study

All published articles of this journal are available on ScienceDirect.

RESEARCH ARTICLE

Association Between Anthropometric Indices and Vitamin D Levels: Results From the Yazd Health Study

The Open Public Health Journal 08 Jun 2026 RESEARCH ARTICLE DOI: 10.2174/011221260304040520

Abstract

Background

Obesity and overweight are widespread health problems affecting many populations. Some studies have shown an inverse association between obesity and vitamin D levels. This study aims to explore the connection between vitamin D levels and various body measurements in Iranian men and women.

Methods

This cross-sectional study used data from the Yazd Health Study. The final sample included 1116 men and women aged 20-70. We measured the following anthropometric indices: Body Mass Index (BMI), Waist-to-Hip Ratio, Waist-to-Height Ratio (WHR), conicity index, Body Roundness Index (BRI), body shape index, Abdominal Volume Index (AVI), Body Fat Percentage (BF%), Body Muscle Percentage (BM%), and visceral fat level. We fitted multiple linear regression models in three steps to adjust for confounders.

Results

In men, after adjusting for age, physical activity, hypertension, and diabetes mellitus, vitamin D deficiency showed a positive and nearly borderline significant association with WHtR (β = 0.027, 95% CI: 0.005; 0.048), BRI (β = 0.583, 95% CI: 0.136; 1.030), AVI (β = 1.761, 95% CI: 0.372; 3.150), and BF% (β = 3.614, 95% CI: 0.926; 6.303), and a negative association with BM% (β = -1.978, 95% CI: -3.655; -0.300). The associations of BRI and BF% with vitamin D deficiency remained borderline significant after further adjustment for other potential confounders. In women, vitamin D levels were not significantly associated with any of the anthropometric indices.

Discussion

Vitamin D levels differentially influence body composition across genders, highlighting potential sex-specific metabolic mechanisms of obesity and vitamin D status, and the need for targeted prevention and intervention strategies.

Conclusion

Vitamin D shows inverse associations with certain body indices in men, highlighting the importance of obesity vulnerability and the need for broader mechanistic studies.

Keywords: Vitamin D deficiency, Anthropometry, Body composition, Adiposity, Sex characteristics, Fat distribution, Overweight, Body mass index, Body muscle percentage.

1. INTRODUCTION

Obesity and overweight are global health challenges affecting over 2.5 billion people worldwide [1]. These conditions have increased rapidly in recent decades, leading to a worldwide epidemic [2]. Both obesity and overweight are linked to many chronic diseases, such as heart disease, Diabetes Mellitus (DM), and various cancers, which lead to significant illness and mortality [3].

Many individuals who are obese or overweight also suffer from low levels of micronutrients and vitamins, especially vitamin D [4, 5]. Vitamin D deficiency is a common problem in many countries, even in regions with sufficient sunlight, like Iran [6]. Vitamin D deficiency can cause or worsen various health problems and chronic diseases, including DM, autoimmune and inflammatory diseases, mental disorders, metabolic syndrome, and obesity [7, 8]. Previous studies have indicated an inverse association between obesity and vitamin D; however, the cause and mechanism of this association are still unclear [9, 10]. Several potential explanations exist, such as reduced availability of vitamin D due to its storage and increase in fat tissue [11], impaired vitamin D synthesis due to liver dysfunction [12], dilution of vitamin D in a larger fat mass [11], and stimulation of fat production in conditions of vitamin D deficiency [13].

Most studies examining the association between obesity and vitamin D have used only limited measures of body size and shape, such as Body Mass Index (BMI) and waist circumference. Few studies have included additional measures. Moreover, previous research in Iran has mainly focused on specific populations. In this study, we used a comprehensive range of both classic and new body size and shape measures to investigate the association between anthropometric indices and vitamin D levels in a cohort of Iranian adults aged 20 to 70 years.

2. MATERIAL AND METHODS

2.1. Study Design

This cross-sectional study used data from the enrollment phase of the Yazd Health Study (YaHS), a prospective cohort study investigating the incidence and risk factors of chronic illnesses in 9965 adults aged 20 to 70 years that has been conducted in the Yazd Greater Area since 2014. We used a cluster-random sampling method to select participants. They completed questionnaires, underwent anthropometric measurements, and provided blood samples for laboratory testing [14]. We excluded participants lacking vitamin D tests or anthropometric measurements, as well as those who were pregnant, had current cancer, Alzheimer's disease, a history of kidney stone surgery, or untreated DM. The final dataset included 1116 subjects aged 20 to 70 years. Details of the exclusions are shown in Fig. (1).

Fig. (1).

Details of the excluded participants of the study.

2.2. Anthropometry

Anthropometric measurements were conducted according to a standard protocol. Body weight was measured with minimal clothing, standing in the middle of the scale, and without assistance, with an accuracy of 0.1 kg using an Omron Model BF511 scale (Omron Inc., Nagoya, Japan). Body Fat Percentage (BF%), Body Muscle Percentage (BM%), and Visceral Fat Level (VFL) were also measured with the same device. Height was measured in a standing position, barefoot, and recorded to the nearest centimeter. BMI was calculated by dividing weight (kg) by the square of the height (m). Waist Circumference (WC) was recorded midway between the iliac crest and the lowest rib, and the Hip Circumference (HC) was measured around the largest circumference of the buttocks. These measurements were taken in a standing position using a non-stretch tape to the nearest 0.5 centimeter [14]. The Waist-to-Hip Ratio (WHR) and Waist-to-Height Ratio (WHtR) were calculated by dividing WC by HC and height, respectively.

The Conicity Index (CI) is an accurate and efficient index for assessing visceral obesity [15]. It is based on the concept that, with the accumulation of fat in the abdominal region, the body changes to a double-cone shape with a common base. CI was computed by the following formula [16]:

Body Roundness Index (BRI) was calculated by WC and height according to the formula [17]:

A Body Shape Index (ABSI) was computed according to the formula [18]:

The Abdominal Volume Index (AVI) is a reliable index for estimating overall abdominal volume [19]. The formula computed AVI by WC (cm) and HC (cm):

2.3. Vitamin D Levels

Vitamin D test results were obtained from the Yazd central laboratory by linking the data with the YaHS participants' records. Serum 25-hydroxy vitamin D (25-OHD) levels were assessed using the vitamin D VIDAS Kit. This kit employs a direct competitive Enzyme-Linked Immunosorbent Assay (ELISA) method. The VIDAS 25-OHD total assay is suitable for measuring vitamins D2 and D3 serum levels with high accuracy [20]. Vitamin D levels were categorized as deficiency (< 20 ng/mL), insufficiency (20-29.9 ng/mL), and normal (≥ 30 ng/mL) [21].

2.4. Potential Confounding Variables

Physical activity was assessed using the International Physical Activity Questionnaire short form (IPAQ-SF) and categorized into three levels: low, moderate, and high [22]. DM, hypertension, thyroid disorders, and high cholesterol were defined based on the self-report presence or absence of these conditions. Participants were grouped into economic quartiles based on housing ownership status, house size (square meters), number of residents in the house, and number of trips per year. Additionally, variables such as age (continuous), smoking status (current, occasional, former, never), illicit drug use (yes, no), medication use in the past month (iron supplement, calcium supplement, vitamins, other supplements, none), marital status (married, single, widowed, divorced), and education level (primary school or less, high school, diploma and graduate diploma, graduation or higher) were considered as confounders.

2.5. Statistical Analysis

All statistical analyses were performed using SPSS software version 26.0 (SPSS Inc., Chicago, IL, USA) separately for men and women. Descriptive results were expressed as the numbers and percentages of participants for categorical variables and as mean ± Standard Deviation (SD) for continuous variables. Univariate generalized linear regression analysis was performed to assess the association between anthropometric indices and potential confounders. Variables showing significant associations were then included in multiple generalized linear regression models across three separate models to explore the association between anthropometric indices and vitamin D levels. All anthropometric indices were included as continuous dependent variables. Vitamin D levels functioned as the independent variable, with levels ≥ 30 ng/mL as the reference group. In model 1, age-adjusted regression coefficients and 95% Confidence Intervals (CI) were calculated. Model 2 was further adjusted for physical activity, DM, and hypertension. Model 3 included additional adjustments for thyroid disorders, high cholesterol, smoking status, illicit drug use, medication use in the last month, marital status, education, and economic quartiles. Variance Inflation Factors (VIFs) assessed multicollinearity among predictor variables. A power analysis for the overall test indicated high power (power = 0.97, total N = 1116, effect size = 0.163, α = 0.05). A P-value less than 0.05 was considered statistically significant.

3. RESULTS

3.1. Descriptive Statistics

A total of 1116 participants were included, of whom 76.8% were women. Participant characteristics are summarized in Table 1. The mean age was 43.88 years for women and 48.80 years for men. Women had higher rates of DM, thyroid problems, and high cholesterol compared to men. Smoking prevalence was 5.3% among women and 22% among men. Almost 86% of the participants were married. Vitamin D deficiency was more common in women (22.5%) than in men (20.1%), whereas vitamin D insufficiency was more prevalent among men (31.5%) compared to women (20.3%). The majority of participants had a BMI indicating an overweight status (25 ≤ BMI < 30), and women had a significantly higher BF% than men (39.54 and 25.94, respectively). Men exhibited higher mean values for WHR, CI, AVI, VFL, and BM%.

Table 1.
Characteristics of participants in the Yazd Health Study during the enrollment phase from 2014 to 2015 and their association with vitamin D levels.
Men (N=259) Women (N=857) p-value
Age (years) 48.8±13.6 43.8±13.7 <0.01*
Physical activity (n (%)) 0.089
Low 127 (49.0) 476 (55.5)
Moderate 114 (44.0) 360 (42.0)
High 14 (5.4) 20 (2.3)
Diabetes mellitus (n (%)) <0.01*
Yes 34 (13.1) 119 (13.9)
No 220 (84.9) 734 (85.6)
Hypertension (n (%)) <0.01*
Yes 49 (18.9) 156 (18.2)
No 205 (79.2) 685 (79.9)
Thyroid problems (n (%)) 0.552
Yes 13 (5.0) 166 (19.4)
No 240 (92.7) 681 (79.5)
High cholesterol (n (%)) <0.01*
Yes 43 (16.6) 181 (21.1)
No 212 (81.9) 664 (77.5)
Smoking (n (%)) 0.889
Current 32 (12.4) 6 (0.7)
Sometimes 5 (1.9) 5 (0.6)
Former 17 (6.6) 5 (0.6)
Never (<100) 202 (78.0) 812 (94.7)
Drugs (n (%)) 0.199
Yes 15 (5.8) 19 (2.2)
No 239 (92.3) 805 (93.9)
Medication use in the last month (n (%)) 0.303
Iron supplement 9 (3.5) 95 (11.1)
Calcium supplement 12 (4.6) 84 (9.8)
Supplemental vitamins 13 (5.0) 30 (3.5)
Other supplements 4 (1.5) 14 (1.6)
No supplement 210 (81.1) 560 (65.3)
Marriage status (n (%)) 0.045*
Married 239 (92.3) 725 (84.6)
Single 18 (6.9) 60 (7.0)
Widowed - 61 (7.1)
Divorced - 5 (0.6)
Education (n (%)) <0.01*
Primary school and less 51 (19.7) 246 (28.7)
High school 76 (29.3) 243 (28.4)
Diploma and graduate diploma 90 (34.7) 244 (28.5)
Graduation or above 40 (15.4) 118 (13.8)
Economic situation (n (%)) <0.01*
Quartile 1 36 (13.9) 143 (16.7)
Quartile 2 72 (27.8) 233 (27.2)
Quartile 3 85 (32.8) 261 (30.5)
Quartile 4 61 (23.6) 167 (19.5)
Vitamin D levels (n (%)) _
Deficiency 52 (20.1) 193 (22.5)
Insufficiency 81 (31.3) 174 (20.3)
Normal 126 (48.6) 490 (57.2)
Body mass index 26.68±4.24 27.77±5.43 <0.01*
Waist-to-hip ratio 0.94±0.08 0.90±0.11 0.675
Waist-to-height ratio 0.56±0.06 0.59±0.09 <0.01*
Conicity index 1.30±0.09 1.29±0.13 0.031*
Body shape index 0.08±0.00 0.08±0.00 0.153
Body roundness index 4.69±1.42 5.46±2.23 <0.01*
Abdominal volume index 18.63±4.30 17.97±5.34 0.022*
Body fat percentage 25.94±8.36 39.54±8.05 <0.01*
Body muscle percentage 33.73±5.22 25.42±3.77 0.011*
Visceral fat level 10.58±4.68 7.95±3.37 <0.01*
Note: Percentage for categorical variables and mean ± SD for continuous variables. * P < 0.05

3.2. Anthropometry and Vitamin D in Men

The levels of vitamin D according to anthropometric indices in men are summarized in Table 2. Through multiple linear regression by adjusting age in model 1, WHtR (β = 0.026, 95% CI: 0.004; 0.047), BRI (β = 0.552, 95% CI: 0.106; 0.998), AVI (β = 1.799, 95% CI: 0.425; 3.172), and BF% (β = 2.831, 95% CI: 0.119; 5.543) showed a significant and positive association with vitamin D deficiency just in men. In model 2, these associations remained significant after the insertion of physical activity, hypertension, and DM. Moreover, the BM% showed a significant negative association with vitamin D deficiency in men (β = -1.978, 95% CI: -3.655; -0.300). In model 3, these associations were reduced, and the association in WHtR, AVI, and BM% disappeared after adjusting for other confounders. Model 3 for the association between anthropometric indices and vitamin D deficiency for BF% showed a 2.907% (95%CI: 0.095; 5.720) increase compared to BRI (β = 0.480, 95% CI: 0.011; 0.948) in men. The association of BMI, WHR, CI, ABSI, VFL, and BM% with vitamin D levels was not significant in men (Supplementary Material ). Model fit was assessed using the Akaike Information Criterion (AIC), with model 3 demonstrating the best balance between goodness-of-fit across all anthropometric indices.

Table 2.
The association between anthropometric measurements and vitamin D levels in men participants of the Yazd Health Study.
Measurements Models Deficient vitamin D
(< 20 ng/ml)
Insufficient vitamin D
(20-29.9 ng/ml)
normal vitamin D (≥ 30 ng/ml) AIC
β (95% CI) P-value β (95% CI) p-value
Body mass index 1 1.139 (-0.225; 2.503) 0.10 -0.662(-1.840; 0.515) 0.27 1 1486.71
2 1.152 (-0.239; 2.542) 0.10 -0.647(-1.851; 0.556) 0.29 1405.20
3 0.740 (-0.720; 2.200) 0.32 -0.809(-2.102; 0.484) 0.22 1258.87
Waist-to-hip ratio 1 0.022 (-0.004; 0.047) 0.10 0.007 (-0.016; 0.029) 0.56 1 -569.68
2 0.018 (-0.007; 0.042) 0.15 0.001 (-0.020; 0.022) 0.94 -571.30
3 0.014 (-0.012; 0.040) 0.27 -0.003(-0.026; 0.020) 0.82 -497.50
Waist-to-height ratio 1 0.026 (0.004; 0.047) * 0.01* -0.001(-0.019; 0.017) 0.92 1 -668.77
2 0.027 (0.005; 0.048) * 0.01* -0.001(-0.019; 0.018) 0.93 -641.97
3 0.022 (-0.001; 0.044) 0.05 -0.005 (-0.025; 0.014) 0.60 -564.10
Conicity index 1 0.030 (-0.001; 0.061) 0.06 0.015 (-0.012; 0.042) 0.27 1 -469.71
2 0.030 (-0.002; 0.061) 0.06 0.015 (-0.013; 0.042) 0.29 -453.43
3 0.028 (-0.004; 0.061) 0.09 0.011 (-0.018; 0.040) 0.46 -399.77
Body shape index 1 0.001 (-0.001; 0.003) 0.25 0.001 (0.000; 0.003) 0.14 1 -1892.61
2 0.001 (-0.001; 0.003) 0.25 0.001 (0.000; 0.003) 0.15 -1796.83
3 0.001 (0.000; 0.003) 0.23 0.001 (0.000; 0.003) 0.24 -1595.58
Body roundness index 1 0.552 (0.106; 0.998) * 0.01* -0.009(-0.394; 0.376) 0.96 1 908.058
2 0.583 (0.136; 1.030) * 0.01* -0.004(-0.392; 0.383) 0.98 849.686
3 0.480 (0.011; 0.948) * 0.04 -0.102(-0.517; 0.313) 0.63 763.439
Abdominal volume index 1 1.799 (0.425; 3.172) * 0.01* -0.013(-1.198; 1.173) 0.98 1 1490.43
2 1.761 (0.372; 3.150) * 0.01* -0.041(-1.243; 1.162) 0.94 1404.83
3 1.411 (-0.045; 2.867) 0.05 -0.190(-1.480; 1.099) 0.77 1257.61
Body fat percentage 1 2.831 (0.119; 5.543) * 0.04* -0.045(-2.370; 2.280) 0.97 1 1816.39
2 3.614 (0.926; 6.303) * 0.00* 0.226 (-2.088; 2.539) 0.84 1710.86
3 2.907 (0.095; 5.720) * 0.04* -0.037(-2.514; 2.441) 0.98 1527.67
Body muscle percentage 1 -1.484 (-3.165; 0.198) 0.08 -0.313(-1.760; 1.134) 0.67 1 1565.60
2 -1.978 (-3.655; -0.300) * 0.02* -0.448(-1.892; 0.995) 0.54 1481.65
3 -1.698 (-3.475; 0.079) 0.06 -0.456(-2.022; 1.109) 0.56 1329.38
Visceral fat level 1 0.914 (-0.557; 2.384) 0.22 -0.918(-2.189; 0.353) 0.15 1 1484.93
2 1.072 (-0.457; 2.600) 0.16 -0.886(-2.213; 0.440) 0.19 1418.30
3 0.634 (-0.949; 2.216) 0.43 -1.118(-2.523; 0.287) 0.11 1263.71
Note: *P < 0.05. Vitamin D at a normal level was considered as a Ref. Model 1 adjusted by age. Model 2 was additionally adjusted for physical activity, diabetes mellitus, and hypertension. Model 3 was additionally adjusted for thyroid problems, high cholesterol, smoking categories, drugs, medication use, marriage status, education, and economic situation. AIC: Akaike Information Criterion.

3.3. Anthropometry and Vitamin D in Women

Vitamin D levels in women according to anthropometric indices were summarized in Table 3. The association between these indices and vitamin D levels was not statistically significant across any models (Supplementary Material ). The study had adequate statistical power to detect differences between groups (power = 0.97).

Table 3.
The association between anthropometric measurements and vitamin D levels in women participants of the Yazd Health Study.
Measurements Models Deficient vitamin D
(< 20 ng/ml)
Insufficient vitamin D
(20-29.9 ng/ml)
normal vitamin D (≥ 30 ng/ml) AIC
β (95% CI) P-value β (95% CI) p-value
Body mass index 1 0.193 (-0.695;1.080) 0.67 -0.174 (-1.060; 0.713) 0.70 1 5220.78
2 0.256 (-0.633; 1.144) 0.57 -0.042 (-0.935; 0.851) 0.92 5091.47
3 0.140 (-0.864; 1.145) 0.78 -0.598 (-1.647; 0.451) 0.26 4074.34
Waist-to-hip ratio 1 0.007 (-0.013; 0.028) 0.48 -0.005 (-0.025; 0.015) 0.63 1 -1244.00
2 0.009 (-0.011; 0.030) 0.37 -0.004 (-0.024; 0.017) 0.71 -1225.69
3 0.001 (-0.021; 0.023) 0.97 -0.004 (-0.028; 0.019) 0.81 -975.65
Waist-to-height ratio 1 0.000 (-0.015; 0.014) 0.98 -0.003 (-0.018; 0.011) 0.64 1 -1824.74
2 0.002 (-0.012; 0.017) 0.74 -0.001 (-0.015; 0.013) 0.88 -1816.93
3 -0.001 (-0.017; 0.015) 0.90 -0.005 (-0.022; 0.012) 0.56 -1397.38
Conicity index 1 0.001 (-0.021; 0.022) 0.95 0.002 (-0.019; 0.023) 0.84 1 -1165.06
2 0.004 (-0.017; 0.025) 0.69 0.004 (-0.017; 0.025) 0.70 -1177.01
3 0.004 (-0.020; 0.027) 0.76 0.008 (-0.017; 0.032) 0.53 -899.15
Body shape index 1 6.26 (-0.001; 0.001) 0.99 0.000 (-0.001; 0.002) 0.63 1 -5888.83
2 0.000 (-0.001; 0.002) 0.77 0.000 (-0.001; 0.002) 0.57 -5780.86
3 0.000 (-0.001; 0.002) 0.74 0.000 (-0.001; 0.002) 0.29 -4552.97
Body roundness index 1 -0.046 (-0.389; 0.298) 0.79 -0.098 (-0.441; 0.245) 0.57 1 3595.57
2 0.021 (-0.309; 0.351) 0.90 -0.032 (-0.364; 0.300) 0.84 3434.12
3 -0.064 (-0.439; 0.312) 0.74 -0.128 (-0.520; 0.264) 0.52 2768.58
Abdominal volume index 1 0.052 (-0.801; 0.905) 0.90 -0.069 (-0.922; 0.783) 0.87 1 5153.71
2 0.206 (-0.601; 1.014) 0.61 0.109 (-0.703; 0.921) 0.79 4932.09
3 0.143 (-0.779; 1.065) 0.76 -0.058 (-1.020; 0.904) 0.90 3959.84
Body fat percentage 1 0.304 (-1.036; 1.644) 0.65 -0.377 (-1.715; 0.962) 0.58 1 5920.03
2 0.300 (-1.036; 1.637) 0.66 -0.164 (-1.508; 1.181) 0.81 5768.09
3 0.082 (-1.427; 1.592) 0.91 -0.496 (-2.072; 1.080) 0.53 4607.04
Body muscle percentage 1 -0.266 (-0.919; 0.387) 0.42 0.056 (-0.596; 0.708) 0.86 1 4682.97
2 -0.268 (-0.891; 0.355) 0.40 -0.133 (-0.760; 0.494) 0.57 4487.08
3 -0.112 (-0.783; 0.559) 0.74 0.063 (-0.638; 0.764) 0.86 3528.65
Visceral fat level 1 -0.214 (-0.668; 0.241) 0.35 -0.338 (-0.794; 0.119) 0.14 1 4055.22
2 -0.191 (-0.642; 0.261) 0.40 -0.293 (-0.750; 0.163) 0.20 3938.48
3 -0.264 (-0.787; 0.259) 0.32 -0.526 (-1.073; 0.021) 0.06 3197.92
Note:*P < 0.05. Vitamin D at a normal level was considered a Ref. Model 1 adjusted by age. Model 2 was additionally adjusted for physical activity, diabetes mellitus, and hypertension. Model 3 was additionally adjusted for thyroid problems, high cholesterol, smoking categories, drugs, medication use, marriage status, education, and economic situation. AIC: Akaike Information Criterion.

3.4. Collinearity Assessment

The highest VIF among predictors was 2.310, indicating moderate multicollinearity. This suggests the predictor variables are sufficiently independent for reliable interpretation of the regression coefficients.

4. DISCUSSION

In this cross-sectional study, we investigated the association of various body size and shape measures, both classic and novel, and vitamin D levels by sex in a cohort of Iranian adults. Our findings showed that the association between anthropometric indices and vitamin D levels differed between men and women. BRI and BF% were negatively associated with vitamin D levels in men, particularly in cases of vitamin D deficiency, but this association was not observed in cases of vitamin D insufficiency. In women, anthropometric measurements were not linked to vitamin D levels.

Alongside traditional indicators like BMI for general obesity and WHR for abdominal obesity, new anthropometric measures, such as BRI, ABSI, CI, and AVI, have been proposed. These newer anthropometric measurements, such as BRI, ABSI, CI, and AVI, are accurate predictors of visceral adiposity [15, 23-25]. Body composition measurement parameters provide valuable information about health and various diseases, including obesity. In this study, we also examined VFL, BF%, and BM% of body composition measurements, in addition to these anthropometric measurements. Visceral fat is an endocrine organ that contributes to the development of metabolic abnormalities associated with abdominal obesity [26].

In our findings, WHtR showed a weak inverse association with vitamin D in men after adjusting for age, physical activity, hypertension, and DM. However, in the final model, none of the BMI, WHR, and WHtR indicators showed significant associations with vitamin D in either sex. Different studies reported conflicting results. One study examining the association between vitamin D and subsequent annual changes in body weight or waist circumference (modified by genetic variants) found almost no association [27]. Conversely, another recent study reported that WHR and WHtR were inversely associated with vitamin D levels, while BMI was not significantly associated in men [28]. A prospective study showed a borderline association between insufficient vitamin D at baseline and increased waist circumference and weight (with age control) among men, but not in women [29]. Additionally, a cross-sectional study of subjects aged 37–47 found that vitamin D levels were lower in obese individuals compared to those with normal weight in both the total population and men, but this difference was not significant in women [30]. A study of women with class II/III obesity (BMI ≥ 35 kg/m2) did not show any association between serum vitamin D levels and BMI and WC [31]. Similarly, in a study of postmenopausal women, no association was observed between vitamin D and BMI, WC, and HC indicators [32]. On the other hand, a study among Italians showed that higher BMI, WHR, and WHtR were associated with lower vitamin D levels, especially in women [2]. One of the main factors behind differences in study results is the control of confounding factors and the methodological approaches used. Sex-specific physiological mechanisms could also explain differences between men and women. Specifically, estrogen plays a significant role in obesity development and its pathophysiological consequences in women [33].

Our results indicated that BRI and AVI have an inverse association with vitamin D in men. However, the association for BRI was borderline significant. Although this association was strong for AVI, controlling for additional confounders caused this significance to disappear. The CI and ABSI indices showed no significant association with vitamin D in either sex across all models. Our findings are somewhat similar to previous studies. A cross-sectional study investigated ABSI, CI, and BRI indices and found a negative association between these anthropometrics and vitamin D levels, except for ABSI in women [28]. A study in China reported an inverse association between ABSI and BRI with vitamin D; this association was significant in men but not in women [23]. Another study on Chinese adults reported that ABSI and BRI were weakly associated with lower vitamin D levels [34]. An investigation of individuals aged 65 years and older reported an association between higher BRI and ABSI [35] and lower vitamin D levels [36]. To our knowledge, only one study has investigated the association between AVI and the average dietary intake of vitamin D, and its results showed a weak correlation between vitamin D and AVI [37]. Various factors could explain these discrepancies, including genetic influences that affect serum vitamin D levels and obesity [38, 39]. Due to high costs and difficulties, it is partially impossible to control genetic factors in these studies. Different countries have diverse policies on food fortification with vitamin D [40], and another reason for differences in results across countries could be the lack of control over the consumption of fortified food. Additionally, observed gender differences may relate to women being more sensitive to their body weight and shape, prompting them to engage more in exercise, dieting, supplements, and other weight-control strategies.

In men, our results showed a borderline inverse association between BF% and vitamin D, but no significant association was found for VFL. After adjusting for age, physical activity, DM, and hypertension, BM% showed a strong negative association with vitamin D deficiency. In women, body composition measurements showed no significant association with vitamin D levels. Consistent with our results, some previous studies have reported that BF% is inversely associated with vitamin D [28, 41]. Additionally, a study involving participants aged 55 years and older reported that vitamin D-deficient individuals had a higher BF% [42]. However, a study on women with BMI ≥ 30 kg/m2 stated no association between vitamin D levels and BF% [31]. Furthermore, a study in Caucasian young adults reported no association between vitamin D receptor genes with BF% and VFL [43]. Many prior studies have shown that vitamin D deficiency correlates positively with reduced muscle mass [44, 45]. Several factors can influence serum vitamin D levels, including race and ethnicity, skin pigmentation, latitude and sunlight exposure, outdoor activities, seasonal variation, and diet. These factors are difficult to control and may not be possible in all studies, which could partly explain the inconsistent findings. Another reason for conflicting results may be differences in the instruments and methods used to measure fat distribution, as well as variations in the method and cutoff points for serum vitamin D levels. Sex differences in body composition might also contribute to the disparities between men and women. Men typically accumulate more visceral abdominal fat, leading to the android body shape, while women tend to display gynoid obesity, accumulating more fat in the subcutaneous and gluteal-femoral regions [46].

Generally, many studies suggest possible explanations for the association between vitamin D and Obesity, but the mechanisms remain unclear. One hypothesis is that the hydrophobicity of vitamin D and its trapping in large adipose tissue reduce its availability for additional hydroxylation by the liver and the kidneys [47]. Additionally, Vitamin D accumulation as a fat-soluble vitamin in adipose tissue and volumetric dilution due to large body size lead to lower plasma levels of 25(OH)D in obese individuals [48, 49]. Recent studies indicate that obesity is associated with decreased expression of genes involved in vitamin D metabolism [50, 51]. Another hypothesis is that individuals with obesity may have a different lifestyle, including less outdoor activity and wearing more clothing, which reduces sun exposure [52]. There are various hypotheses on this topic, and opinions differ.

5. STRENGTHS AND LIMITATIONS

In our study, a broad range of anthropometric and body-composition measurements was investigated in a representative sample of the population. For all participants, anthropometric indices, vitamin D levels, and other measurements were obtained by trained researchers using the same equipment and methods. However, our study has limitations, including the inability to accurately control for supplementation and for the season in which vitamin D measurements were taken. Considering the possibility of over-the-counter vitamin D supplements in Iran, there may have been periodic use, especially among women. However, some studies have indicated that the supplement use and the season of vitamin D measurement did not play a significant role in this association [28, 53]. We could not account for participants' skin type or clothing style. Notably, in Iran, women tend to wear a wider variety of clothing styles, which might influence related factors. Additionally, we were unable to control for individuals with a history of bariatric surgery or varying amounts of sunlight exposure. Since our study was cross-sectional, no causal relationships can be established; large-scale prospective studies are needed in the future to clarify the connection between obesity and vitamin D.

CONCLUSION

The present findings indicate that vitamin D status may be inversely associated with certain anthropometric indices, specifically BRI and BF%, among men. However, such associations were not observed in women. These sex-specific differences suggest that biological or behavioral factors may influence vitamin D metabolism across genders. Given these observations, routine evaluation of vitamin D levels, particularly among individuals with obesity, may be beneficial. Nevertheless, these results should be interpreted cautiously, as further studies across diverse populations are necessary to elucidate underlying mechanisms and validate the reproducibility and generalizability of these associations.

AUTHORS’ CONTRIBUTIONS

The authors confirm their contribution to the paper as follows: Study conception and design: RA; Writing the paper: FSS; Analysis and interpretation of results: SJ; Writing - reviewing and editing: MM. All authors reviewed the results and approved the final version of the manuscript.

LIST OF ABBREVIATIONS

AIC = Akaike Information Criterion
AVI = Abdominal Volume Index
BF% = Body Fat Percentage
BMI = Body Mass Index
BM% = Body Muscle Percentage
BRI = Body Roundness Index
CI = Confidence Intervals
CI = Conicity Index
DM = Diabetes Mellitus
HC = Hip Circumference
SD = Standard Deviation
VFL = Visceral Fat Level
VIFs = Variance Inflation Factors
WC = Waist Circumference
WHR = Waist-to-Hip Ratio
WHtR = Waist-to-Height Ratio
YaHS = Yazd Health Study
25-OHD = Serum 25-hydroxy vitamin D

ETHICS APPROVAL AND CONSENT TO PARTICIPATE

Ethical approval was obtained from the Research Ethics Committee of Shahid Sadoughi University of Medical Sciences, Iran with the Ethical ID IR.SSU.SPH.REC.1402.075.

HUMAN AND ANIMAL RIGHTS

All human research procedures followed were in accordance with the ethical standards of the committee responsible for human experimentation (institutional and national), and with the Helsinki Declaration of 1975, as revised in 2013.

CONSENT FOR PUBLICATION

Written informed consent was obtained from all participants before their inclusion in the study.

STANDARDS OF REPORTING

STROBE guidelines were followed.

AVAILABILITY OF DATA AND MATERIALS

The original data used to support the Findings of this study are available from the corresponding author upon request.

FUNDING

None.

CONFLICT OF INTEREST

The authors declare no conflict of interest, financial or otherwise.

ACKNOWLEDGEMENTS

Declared none.

SUPPLEMENTARY MATERIAL

Supplementary material is available on the publisher’s website along with the published article.

REFERENCES

1
Musazadeh V, Zarezadeh M, Ghalichi F, Kalajahi FH, Ghoreishi Z. Vitamin D supplementation positively affects anthropometric indices: Evidence obtained from an umbrella meta-analysis. Front Nutr 2022; 9: 980749.
2
Gammone MA, Danese A, D’Orazio N. Prevalence of 25(OH)D insufficiency and overweight/obesity in an adult population from the Central Italy. Clin Ter 2022; 173(4): 334-41.
3
Cordeiro A, Luna M, Pereira SE, Saboya CJ, Ramalho A. Impairment of Vitamin D nutritional status and metabolic profile are associated with worsening of obesity according to the edmonton obesity staging system. Int J Mol Sci 2022; 23(23): 14705.
4
Haghighat N, Sohrabi Z, Bagheri R, et al. A systematic review and meta-analysis of vitamin D status of patients with severe obesity in various regions worldwide. Obes Facts 2023; 16(6): 519-39.
5
Karampela I, Sakelliou A, Vallianou N, Christodoulatos GS, Magkos F, Dalamaga M. Vitamin D and obesity: Current evidence and controversies. Curr Obes Rep 2021; 10(2): 162-80.
6
Hashemipour S, Larijani B, Adibi H, et al. Vitamin D deficiency and causative factors in the population of Tehran. BMC Public Health 2004; 4(1): 38.
7
Wang H, Chen W, Li D, et al. Vitamin D and Chronic Diseases. Aging Dis 2017; 8(3): 346-53.
8
Prasad P, Kochhar A. Interplay of vitamin D and metabolic syndrome: A review. Diabetes Metab Syndr 2016; 10(2): 105-12.
9
Pereira-Santos M, Costa PRF, Assis AMO, Santos CAST, Santos DB. Obesity and vitamin D deficiency: a systematic review and meta‐analysis. Obes Rev 2015; 16(4): 341-9.
10
González L, Ramos-Trautmann G, Díaz-Luquis GM, Pérez CM, Palacios C. Vitamin D status is inversely associated with obesity in a clinic-based sample in Puerto Rico. Nutr Res 2015; 35(4): 287-93.
11
Guasch A, Bulló M, Rabassa A, et al. Plasma vitamin D and parathormone are associated with obesity and atherogenic dyslipidemia: a cross-sectional study. Cardiovasc Diabetol 2012; 11(1): 149.
12
Al-Mutawa A, Anderson A, Alsabah S, Al-Mutawa M. Nutritional status of bariatric surgery candidates. Nutrients 2018; 10(1): 67.
13
McCarty MF, Thomas CA. PTH excess may promote weight gain by impeding catecholamine-induced lipolysis-implications for the impact of calcium, vitamin D, and alcohol on body weight. Med Hypotheses 2003; 61(5-6): 535-42.
14
Mirzaei M, Salehi-Abargouei A, Mirzaei M, Mohsenpour MA. Cohort Profile: The Yazd Health Study (YaHS): A population-based study of adults aged 20–70 years (study design and baseline population data). Int J Epidemiol 2018; 47(3): 697-698h.
15
Roriz AKC, Passos LCS, de Oliveira CC, Eickemberg M, Moreira PA, Sampaio LR. Evaluation of the accuracy of anthropometric clinical indicators of visceral fat in adults and elderly. PLoS One 2014; 9(7): e103499.
16
Valdez R. A simple model-based index of abdominal adiposity. J Clin Epidemiol 1991; 44(9): 955-6.
17
Thomas DM, Bredlau C, Bosy-Westphal A, et al. Relationships between body roundness with body fat and visceral adipose tissue emerging from a new geometrical model. Obesity (Silver Spring) 2013; 21(11): 2264-71.
18
Krakauer NY, Krakauer JC. A new body shape index predicts mortality hazard independently of body mass index. PLoS One 2012; 7(7): e39504.
19
Guerrero-Romero F, Rodríguez-Morán M. Abdominal volume index. an anthropometry-based index for estimation of obesity is strongly related to impaired glucose tolerance and type 2 diabetes mellitus. Arch Med Res 2003; 34(5): 428-32.
20
Moreau E, Bächer S, Mery S, Goff CL, Piga N, Vogeser M. Performance characteristics of the VIDAS® 25-OH Vitamin D Total assay – comparison with four immunoassays and two liquid chromatography-tandem mass spectrometry methods in a multicentric study. Clin Chem Lab Med 2016; 54: 45.
21
Holick MF. The vitamin D deficiency pandemic: Approaches for diagnosis, treatment and prevention. Rev Endocr Metab Disord 2017; 18(2): 153-65.
22
Craig CL, Marshall AL, Sjöström M, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 2003; 35(8): 1381-95.
23
Zhu XL, Chen ZH, Li Y, et al. Associations of vitamin D with novel and traditional anthropometric indices according to age and sex: a cross-sectional study in central southern China. Eat Weight Disord 2020; 25(6): 1651-61.
24
Nagayama D, Fujishiro K, Watanabe Y, et al. A Body Shape Index (ABSI) as a Variant of Conicity Index Not Affected by the Obesity Paradox: A Cross-Sectional Study Using Arterial Stiffness Parameter. J Pers Med 2022; 12(12): 2014.
25
Wang H, Liu A, Zhao T, et al. Comparison of anthropometric indices for predicting the risk of metabolic syndrome and its components in Chinese adults: a prospective, longitudinal study. BMJ Open 2017; 7(9): e016062.
26
Fontana L, Eagon JC, Trujillo ME, Scherer PE, Klein S. Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes 2007; 56(4): 1010-3.
27
Larsen SC, Ängquist L, Moldovan M, et al. Serum 25-hydroxyvitamin D status and longitudinal changes in weight and waist circumference: influence of genetic predisposition to adiposity. PLoS One 2016; 11(4): e0153611.
28
Patriota P, Rezzi S, Guessous I, Marques-Vidal P. Association between anthropometric markers of adiposity, adipokines and vitamin D levels. Sci Rep 2022; 12(1): 15435.
29
Jääskeläinen T, Männistö S, Härkänen T, Sääksjärvi K, Koskinen S, Lundqvist A. Does vitamin D status predict weight gain or increase in waist circumference? Results from the longitudinal Health 2000/2011 Survey. Public Health Nutr 2020; 23(7): 1266-72.
30
Saarnio E, Pekkinen M, Itkonen ST, et al. Low free 25-hydroxyvitamin D and high vitamin D binding protein and parathyroid hormone in obese Caucasians. A complex association with bone? PLoS One 2018; 13(2): e0192596.
31
Silveira EA, Costa Silveira L, de Souza Cardoso CK, et al. Vitamin D in women with class II/III obesity: Findings from the DieTBra trial. Clin Nutr ESPEN 2023; 55: 83-9.
32
Moschonis G, Tanagra S, Koutsikas K, Nikolaidou A, Androutsos O, Manios Y. Association between serum 25-hydroxyvitamin D levels and body composition in postmenopausal women. Menopause 2009; 16(4): 701-7.
33
Leeners B, Geary N, Tobler PN, Asarian L. Ovarian hormones and obesity. Hum Reprod Update 2017; 23(3): 300-21.
34
Ren Z, Zhao A, Wang Y, et al. Association of serum 25‐hydroxy vitamin D with obesity‐related indices in Chinese adults: A cross‐sectional study. Food Sci Nutr 2021; 9(4): 2260-8.
35
Cakir M, Ozkaya Y, Terzi NE, Aygun O, Kucukerdem HS, Saki E. The relationship between vitamin D levels, comprehensive geriatric assessment and anthropometric measurements. PLoS One 2025; 20(8): e0329649.
36
Sousa-Santos AR, Afonso C, Santos A, et al. The association between 25(OH)D levels, frailty status and obesity indices in older adults. PLoS One 2018; 13(8): e0198650.
37
Alkhatib B, Agraib LM, Al-Dalaeen A, Al-Shami I. Are There any correlations between vitamin D, calcium, and magnesium intake and coronary and obesity indices? J Am Nutr Assoc 2024; 43(1): 12-9.
38
Sepulveda-Villegas M, Elizondo-Montemayor L, Trevino V. Identification and analysis of 35 genes associated with vitamin D deficiency: A systematic review to identify genetic variants. J Steroid Biochem Mol Biol 2020; 196: 105516.
39
Endalifer ML, Diress G. Epidemiology, Predisposing Factors, Biomarkers, and Prevention Mechanism of Obesity: A Systematic Review. J Obes 2020; 2020: 1-8.
40
Peterlik M, Boonen S, Cross HS, Lamberg-Allardt C. Vitamin D and calcium insufficiency-related chronic diseases: an emerging world-wide public health problem. Int J Environ Res Public Health 2009; 6(10): 2585-607.
41
Hannemann A, Thuesen BH, Friedrich N, et al. Adiposity measures and vitamin D concentrations in Northeast Germany and Denmark. Nutr Metab (Lond) 2015; 12(1): 24.
42
Vitezova A, Muka T, Zillikens MC, et al. Vitamin D and body composition in the elderly. Clin Nutr 2017; 36(2): 585-92.
43
Correa-Rodríguez M, Carrillo-Ávila JA, Schmidt-RioValle J, et al. Genetic association analysis of vitamin D receptor gene polymorphisms and obesity-related phenotypes. Gene 2018; 640: 51-6.
44
Luo S, Chen X, Hou L, et al. The Relationship between Sarcopenia and Vitamin D Levels in Adults of Different Ethnicities: Findings from the West China Health and Aging Trend Study. J Nutr Health Aging 2021; 25(7): 909-13.
45
Jung HN, Jung CH, Hwang YC. Sarcopenia in youth. Metabolism 2023; 144: 155557.
46
Palmer BF, Clegg DJ. The sexual dimorphism of obesity. Mol Cell Endocrinol 2015; 402: 113-9.
47
Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 2000; 72(3): 690-3.
48
Blum M, Dolnikowski G, Seyoum E, et al. Vitamin D3 in fat tissue. Endocrine 2008; 33(1): 90-4.
49
Drincic AT, Armas LAG, van Diest EE, Heaney RP. Volumetric dilution, rather than sequestration best explains the low vitamin D status of obesity. Obesity (Silver Spring) 2012; 20(7): 1444-8.
50
Elkhwanky MS, Kummu O, Piltonen TT, et al. Obesity Represses CYP2R1, the Vitamin D 25‐Hydroxylase, in the Liver and Extrahepatic Tissues. JBMR Plus 2020; 4(11): e10397.
51
Roizen JD, Long C, Casella A, et al. Obesity decreases hepatic 25‐hydroxylase activity causing low serum 25‐hydroxyvitamin D. J Bone Miner Res 2019; 34(6): 1068-73.
52
Pourshahidi LK. Vitamin D and obesity: current perspectives and future directions. Proc Nutr Soc 2015; 74(2): 115-24.
53
Mai XM, Chen Y, Camargo CA Jr, Langhammer A. Cross-sectional and prospective cohort study of serum 25-hydroxyvitamin D level and obesity in adults: the HUNT study. Am J Epidemiol 2012; 175(10): 1029-36.